TODAYS UPDATE FROM MANAGEMENT IS REALISTIC, CERTAINLY NOT EXCILERATING BUT ALSO NOT NEGATIVE AS WELL. THE COMPANY, IN ALL ITS VARIOUS REVENUE PRODUCING MEANS, ARE MOVING FORWARD. SOUND BUILDING IN ALL SECTORES, BUT NOT THE EXTREME POSITIVE THAT MANY INVESTORS THOUGHT WOULD HAPPEN WITH THE BIO SECTION. I STILL THINK THE SHARE PRICE IS NOT REFLECTING THE POTENTIAL OF THE COMPANY, BUT IMPATIENCE SEEMS TO BE HOLDING BACK THE SHARE PRICE.REALITY IS ALWAYS EARNINGS.